Dr. Sulaiman Al-habib Medical Services Group Co. · TADAWUL:4013

Dr. Sulaiman Al-habib Medical Services — Q1 2026 Earnings Presentation

37 slides from Dr. Sulaiman Al-habib Medical Services's earnings presentation, May 5, 2026

  1. Slide 1: Q1 2026 Investor Presentation

    Q1 2026 Investor Presentation As of 05 May 2026

  2. Slide 2: Presenting Team

    Presenting Team Ziyad Al Dahami Faisal Al Nassar Esam Al Mashloum Head of Investor Relations and Treasury Chief Executive Officer Vice President, Finance Q1 2026 HMG Investor Presentation

  3. Slide 3: Agenda

    Agenda 1 Financial Performance 2 Projects Update 3 Q&A Key Financial Highlights 5 Projects Update – Completed Projects 11 Q&A 13 Balance Sheet Highlights 6 Projects Update – Future Projects 12 Financial Performance Indictors 7 Leverage Levels 8 Declared Cash Dividends 9 Appendices Appendix #1 Append

  4. Slide 4: Financial Performance

    1 Financial Performance

  5. Slide 5: Key Financial Highlights: Q1 2026

    Key Financial Highlights: Q1 2026 Gross Profit (7.04)% Gross Profit Margin % Q1 2026 956 Q1 2026 27.82% 1,028 Q1 2025 Q1 2025 32.56% EBITDA 4.59% EBITDA Margin % 854 24.84% Q1 2026 Q1 2026 816 25.84% Q1 2025 Q1 2025 Net Income (9.64)% Net Income Margin % 14.65% Q1 2026 503 Q1 2026 17.64% Q1 2025 557

  6. Slide 6: Balance Sheet Highlights

    Balance Sheet Highlights 6 Q1 2026 HMG Investor Presentation

  7. Slide 7: Financial Performance Indicators: Q1 2026

    Financial Performance Indicators: Q1 2026 ROE Current Ratio Inventory 26.42% 1.14x 38 Days 32.00% 1.18x 35 ROA Receivables Cash Cycle 8.92% 37 Days (2) Days 11.66% 26 (14) ROCE Payables 13.16% 80 Days 75 Q1 2026 Q1 2025 16.50% Increase Decrease The same range 7 Q1 2026 HMG Investor Presentation

  8. Slide 8: Leverage Levels

    Leverage Levels 120.00% Total liabilities and equity million Liabilities/Total Assets Liabilities/Equity 100.00% 0.64x 1.80x Q1 2026 Q1 2026 Q1 2025 0.64x Q1 2025 1.76x 80.00% 36.29% 35.71% 7,752 8,487 60.00% Debt / Equity Net Debt / EBITDA Q1 2026 1.13x Q1 2026 2.09x 40.00% 1.11x Q1 2025 1.87x Q1 2

  9. Slide 9: Declared Cash Dividends

    Declared Cash Dividends Declared Dividends Pay-out Declared Cash Dividends – Q1 2026 2026 1.01 per share 353.5 mn 70.2% Current Capital 3.5 billion 70.4% 1.31 per share 458.50 mn Number of Shares 350 million 70.3% 1.21 per share 423.50 mn Dividend to be Distributed 353.5 million 2025 1.12per pershar

  10. Slide 10: Projects Update

    2 Projects Update

  11. Slide 11: Projects Update – Completed Projects

    Projects Update – Completed Projects Solidifying our market leadership through robust expansion plans and progressing our projects 2024 Al Fayhaa Hospital Women’s Health Al Sahafa Hospital Hospital Ownership Ownership Ownership 50% 100% 100% Jeddah Riyadh Riyadh Opened on Opened on Opened on March 2

  12. Slide 12: Projects Update – Future Projects

    Projects Update – Future Projects Solidifying our market leadership through robust expansion plans and progressing our projects Tabuk Hospital Jubail Industrial City Hospital Red Sea Hospital Ownership Ownership Operating and 100% 100% Management Contract Jubail Tabuk Industrial Red Sea City Expecte

  13. Slide 13: Q&A

    3 Q&A OVERVIEW STRATEGIC REVIEW OPERATING REVIEW GOVERNANCE

  14. Slide 14: Appendix #1: Operational Highlights

    4 Appendix #1 Operational Highlights

  15. Slide 15: Q1 2026 Key Highlights

    Q1 2026 Key Highlights ESG Highlight Key Highlight Implemented an ESG supplier engagement exercise for a limited number of high-spend strategic suppliers to Agreement with the Saudi Cycling Federation to improve our visibility and understanding of ESG sponsor the 2026 Asian Road Cycling Championship

  16. Slide 16: Q1 2026 Key Highlights

    Q1 2026 Key Highlights HMG App Highlight Q1 2026 Recognitions Interaction Booked Appointments +280m +1.8m interactions Joint Commission International College of American Pathology appointments Accreditation (JCI) Accreditation (CAP) Habib Live Care Home Healthcare +135k +11.6k Association for the Ad

  17. Slide 17: Medical Excellence

    Medical Excellence Creating the medical practitioners of the future and promoting health and well-being Continuous Medical Research Center Postgraduate Program Education 1 Journal issued 92 Activities 200+ Hours 55+ 34 research paper published Residency & Fellowship program 45+ Research proposals su

  18. Slide 18: Our People

    Our People We continue to attract and retain top talent Physician Qualifications 25.5k+ 59% female staff Payroll staff 41% male staff 45% 6,000+ 90%+ Physicians Retention Rate 28% 90+ 42% Nationalities Saudi national staff 27% Training via Virtual Academy Platform Saudi Western (Including North Amer

  19. Slide 19: Investment Case

    Investment Case Attractive Industry Fundamentals HMG is committed to patient safety and wellbeing, providing patients with the highest standards of Adaptable Operating Model medical technology, exceptional patient experiences and sustainability to consistently deliver best-in-class care through its

  20. Slide 20: Appendix #2: Summarized Financials

    5 Appendix #2 Summarized Financials

  21. Slide 21: Financial Review

    Financial Review Key Financial Information and KPIs Q1 2026 Q1 2025 Statement of Income million Revenue 3,436 3,158 Gross profit 956 1,028 Operating income 588 626 Profit attributable to equity holders of the parent 503 557 Balance Sheet million Current assets 5,647 5,244 Non-current assets 18,119 1

  22. Slide 22: Financial Review (Continued)

    Financial Review (Continued) Key Financial Information and KPIs Q1 2026 Q1 2025 Cash Flows million Net cash from operating activities 1,055 734 Net cash used in investing activities (540) (934) Net cash used in financing activities (381) (143) Cash and Cash Equivalents, Beginning of the Period 2,282

  23. Slide 23: Appendix #3: About HMG

    6 Appendix #3 About HMG

  24. Slide 24: About HMG

    Care for About HMG Patients and Communities Intelligent at Exceptional the Core Talent Our Values Our values define who we are, providing a clear sense of purpose and the motivation to deliver exceptional outcomes for all our stakeholders. They Think Big and Act Fast Accountability guide our strateg

  25. Slide 25: About HMG (continued)

    About HMG (continued) HMG Universe Medical Diagnostic Laboratories (MD Labs) provide HMG Hospitals deliver comprehensive secondary specialized testing services that deliver high-quality and tertiary healthcare services, offering an results with exceptional speed. MD Labs adopted extensive range of s

  26. Slide 26: Key Message

    Key Message Strategic pillars underpin our drive to deliver best-in-class healthcare services Catalysts for value Best-in-class Efficiency drivers creation • Technology: Pioneer in healthcare • Efficient cash conversion cycle: • Regional integrated healthcare technology, award-winning hospital short

  27. Slide 27: Geographic Footprint

    Geographic Footprint 25+ 6,000+ 44 60+ Medical Physicians Pharmacies Sub- Facilities specialties 1. Sahafa (Riyadh) 8. Fayhaa (Jeddah) 2. Olaya (Riyadh) 9. Muhammadiyah (Jeddah) 3. Takhassusi (Riyadh) 10. Qassim 4. Rayan (Riyadh) 11. Khobar 5. Suwaidi (Riyadh) 12. Kharj 6. Women’s Health (Riyadh) 13

  28. Slide 28: Geographic Footprint (continued)

    Geographic Footprint (continued) Our vast footprint across Riyadh MAP KEY Hospitals Medical Centers Hospitals Head Office Under Construction Urgent HMG Academy and Care Collage for Knowledge Pharmacy 28 Q1 2026 HMG Investor Presentation

  29. Slide 29: Strategy

    Strategy OUR PILLARS Drivers Outcomes Our Growth Strategy Strengthening • Rigorous quality and safety standards • Patient and customer-centric Built around clarity of purpose and disciplined execution, our • Top-notch empowered employees value service delivery the Core corporate strategy is designed

  30. Slide 30: Business Model

    Business Model OUR KEY STRENGTHS WHAT WE DO HMG is uniquely positioned as the leading • Forefront Of Technology and Innovation • Modern Facilities and Comprehensive Services private healthcare group in the region, with the expertise, experience and culture • Trusted Brand in Prime Locations • Sustai

  31. Slide 31: Medical Operation Strategic Pillars

    Medical Operation Strategic Pillars Our Fundamental Strategic Pillars Patient Safety Patient Experience Performance and Since its foundation, transformation and evolution, HMG has Enhancing the safety of our Enhancing patient experience by Efficiency always abided by five key strategic pillars that

  32. Slide 32: Pioneer In Healthcare Technology

    Pioneer In Healthcare Technology Better medical outcomes, exceptional patient experience, and advanced operational practices Tele-medicine Developing cutting edge technology HIS (VIDA) 81 Vida implemented sites Pioneer in healthcare technology, award-winning ▪ Tele-Cardiology (Nabad 24 program): Des

  33. Slide 33: Board of Directors

    Board of Directors Non-executives Executives Independents Mr. Faisal Al Nassar Dr. Sulaiman Al Habib Mr. Obaid Al Rasheed Board member, Group CEO and Group Founder and Chairman CFO Vice Chairman Dr. Abdulrahman Mr. Hesham Al Habib Al Turaigi Eng. Saleh Al Habib Board member and Chief Board member Bo

  34. Slide 34: Committee Members

    Committee Members Audit Nomination and Remuneration Executive Dr. Abdulrahman Al Turaigi Mr. Obaid Al Rasheed Eng. Saleh Al Habib Chairman Chairman Chairman Mr. Turki Al Luhaid Eng. Saleh Al Habib Mr. Faisal Al Nassar Member Member Member Mr. Abdulaziz Al Haidari Mr. Rasheed Al Rasheed Mr. Hesham Al

  35. Slide 35: Executive Management

    Executive Management Highly experienced, high caliber management Mr. Faisal Al Nassar CEO & President CORE FUNCTIONS CORPORATE FUNCTIONS INDEPENDENT FUNCTIONS Eng. Abdullah Dr. Riyad Al Atiqi Prof. Abdullah Al Herbish Mr. Hesham Al Habib Mr. Ahmed Babatin Al Sudais General Director Senior Vice Presi

  36. Slide 36: Disclaimer

    Disclaimer Disclaimer and important information in relation to this presentation This presentation is for general use only and is not necessarily comprehensive as it has not been independently verified, nor is it considered or constitutes part of any invitation or inducement to engage in any investm

  37. Slide 37: Thank You

    Investor Relations Department Thank You King Fahad Road, Olaya District P.O. Box: 91877, Riyadh 11643, Kingdom of Saudi Arabia Phone: + 966 (11) 5259999, Ex. 4919 Fax: + 966 (11) 2174980 Email: investor.relations@drsulaimanalhabib.com OVERVIEW STRATEGIC REVIEW OPERATING REVIEW GOVERNANCE

Dr. Sulaiman Al-Habib Medical Services Group Co. (HMG) — Q1 2026 Earnings Presentation on 6ix